Skip to Content Facebook Feature Image

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru

Business

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru
Business

Business

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru

2025-11-26 10:00 Last Updated At:10:15

First cyclotron outside Klang Valley to anchor Malaysia's advanced cancer care ecosystem

KEY-HIGHLIGTHS

  • RM500 million investment in advanced cancer care infrastructure
  • State-of-the-art diagnostic and treatment facilities, including a nuclear medicine centre
  • First cyclotron outside the Klang Valley enabling local radioisotope production for cancer detection and therapy
  • Located in Larkin Sentral within the Johor–Singapore Special Economic Zone (JS-SEZ)
  • Phase One projected to create around 1,000 direct and indirect jobs

JOHOR BAHRU, Malaysia and SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Singapore-based healthcare provider Precious Medical Group today announced the launch of the Tunku Laksamana Johor Cancer Centre and Hospital, a landmark RM500 million development featuring state-of-the-art diagnostic and treatment facilities. The project aims to elevate oncology capacity in and beyond Johor while strengthening collaboration across Malaysia's public and private healthcare systems.

The first phase of the project, the Tunku Laksamana Johor Cancer Centre, will be inaugurated on 5th December 2025. It will feature advanced diagnostic and treatment capabilities, including a PET-CT and radiotherapy centre. When fully completed, it will also house a nuclear medicine facility equipped with Malaysia's first cyclotron outside the Klang Valley, enabling on-site production of medical radioisotopes for cancer imaging and therapy. This development will enhance early detection, improve treatment availability, and reduce dependence on distant radioisotope supply chains.

Construction and operations are projected to generate around 1,000 direct and indirect jobs, contributing to workforce development and supporting the broader goals of the Johor–Singapore Special Economic Zone (JS-SEZ) to drive high-value healthcare services. Following the centre's launch, Precious Medical Group will proceed with the development of a 200-bed hospital on the same site to provide comprehensive inpatient oncology and integrated support services.

Strategically located at Larkin Sentral, a major transport hub within the JS-SEZ, the project is positioned to facilitate cross-border medical collaboration, talent mobility, and knowledge transfer—further strengthening the resilience, capacity, and international reputation of Malaysia's healthcare system, which already attracts more than 1.5 million medical tourists annually.

The hospital is named after the late Tunku Abdul Jalil, the fourth child of His Majesty Sultan Ibrahim of Johor and Her Majesty Raja Zarith Sofiah, who passed away at the age of 25 after bravely battling liver cancer. The centre was conceived to fulfil his wish of alleviating the suffering of cancer patients.

"This hospital is a tribute to the memory of Tunku Abdul Jalil, whose courage, strength, and resilience in the face of adversity remain an inspiration to all," said Dr William Chong, Founder and Managing Director of Precious Medical Group. "Tunku Jalil's modest, kind, and compassionate nature embodies the philosophy of this hospital — the spirit of caring and sharing."

With the upcoming RTS Link set to enhance cross-border mobility, the Tunku Laksamana Johor Cancer Centre and Hospital will strengthen Johor's role as a gateway for advanced collaboration between Malaysia and Singapore. The project reflects the building of a seamless ecosystem for medical treatment, training, and innovation, serving patients across both nations and the wider region. It stands as a symbol of regional partnership, economic growth, and human progress, positioning Johor as a new focal point for high-value healthcare within ASEAN.

About Precious Medical Group

Precious Medical Group is a leading healthcare provider in Singapore, operating a 14,000 sq ft flagship medical centre at Paragon Medical Tower, offering specialist services, health screening, dentistry, day surgery, and advanced imaging (CT, mammography, and MRI). The Group also operates two nursing homes with 496 licensed beds and nine Active Ageing Centres serving over 6,000 seniors across Singapore. Founded by Dr William Chong, a senior dental surgeon, Precious Medical Group reflects his belief in patient centric, multi-disciplinary care. His lifelong passion for healthcare innovation, and compassion for the underprivileged has driven him to work towards finding solutions to underlying issues, in particular those affecting the elderly, and for patients with cancer. The Tunku Laksamana Johor Cancer Centre and Hospital marks the group's first venture in Malaysia and is owned and operated by its related company Precious Hospital Sdn. Bhd.

Sherrena Koh
Contact:  +60 19 589 3077  |   Email: sherrena@tljcancercentre.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru

PUNE, India, April 2, 2026 /PRNewswire/ -- EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company's comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.

"FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.

India's transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition."

— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility

Strong Business Momentum Across Segments

  • Electric Bus Leadership:
    Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi
  • SCV Breakout Year:
    Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption
  • Electric Trucks:
    New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification
  • Hydrogen Fuel Cell:
    Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses

Key Highlights:

Global Expansion:

  • Commenced electric bus deployments in Africa
  • Partnership with Kerchanshe Group for CKD assembly and distribution
  • Agreement with NBFI Capital for manufacturing in Australia

Manufacturing Scale-Up:

  • Two Pune facilities operational; Pithampur plant to be operational shortly
  • Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs

Retail Network:

  • Expanded dealership network; plans to add 120 dealerships in FY27

Order Book Visibility:

  • 6,000+ confirmed e-buses to be delivered over the next two years

About EKA Mobility

EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India's commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.

EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.

To know more about the company, kindly visit: https://ekamobility.com 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

EKA Mobility Achieves 5x Volume Growth

EKA Mobility Achieves 5x Volume Growth

Recommended Articles